…and suddenly the world finally wakes up!
Amazing how corporate businesses get away with murder, and surely Lundbeck is higher and higher on top of the list!
Indeed 25 murders in the USA obviously were not enough for the death lab to actually gets its head out of the sand and do something real, for a change.
There have been plenty of hypocritical media statements and official objections in letters sent to the various departments of corrections in the US currently stocked up with pentobarbital, thanks to Lundbeck’s criminal negligence from December 2010 to the end of June 2011. Guess what the result has been so far? Nothing, zero, zilch, nada. Are we surprised? No!
And now that Troy Davis has an execution date in Georgia this month, will you finally act and tell Lundbeck how you feel about their death drug before it’s too late? And Troy Davis isn’t Lundbeck’s only future patient, there are 16 more to come by the end of 2011, including Steven Woods in Texas on September 13th, a man who also didn’t kill anyone but is about to die for it.
We went through: “Lethal injection death penalty: Pharmaceutical’s outrage at drug use”, “Lundbeck Urges State of Virgina to Stop Using their Drugs”, and the ultimate ridicule in: “Lundbeck Bans Sale of Drug Used in Executions to US Prisons” by Dr Isis (who obviously still hasn’t found Osiris), who has since moved her blog and is now concentrating on women’s shoes, evidently a research of high medical importance.
If Lundbeck truly intended to contribute its fair and honest share in halting the killings, then why didn’t it:
- Issue medical/scientific analysis to document that pentobarbital was never designed as an anaesthetic and is not safe to be used as such, to assist US attorneys in stopping their clients’ executions;
- Sue the various departments of corrections that purchased, legally or not, pentobarbital to kill human beings;
- Ask the FDA to recover the doses purchased in the US because of its misuse.
As the sole manufacturer of pentobarbital, Lundbeck has stayed clear from legal options and this alone demonstrates its coward objections are nothing but a publicity stunt aimed at improving its image, the image of a death lab that its shareholders are right to quit to move on to healthier investments.
In the meantime, Lundbeck promotes its own staff and cuts jobs. The latest one is astounding for sure: Marie-Laure Pochon, president of Lundbeck France and vice-president of Lundbeck Europe has been promoted to executive vice-president of commercial operations. Another pathetic move! Marie-Laure Pochon is the same person who systematically sent non-answers to French activists when they were asking for tangible answers and who didn’t bother replying to NGO’s seeking a meeting with her to discuss the pentobarbital issue. So yeah, that’s some kind of promotion that merely confirms Lundbeck’s only and true incentive: business and profit. Forget about human lives and health care, evidently that’s never been part of Lundbeck’s goals or priorities.